| Photoswitchable nanoparticles for triggered tissue penetration and drug delivery R Tong, HD Hemmati, R Langer, DS Kohane Journal of the American Chemical Society 134 (21), 8848-8855, 2012 | 474 | 2012 |
| Reversible cell‐specific drug delivery with aptamer‐functionalized liposomes Z Cao, R Tong, A Mishra, W Xu, GCL Wong, J Cheng, Y Lu Angewandte Chemie International Edition 48 (35), 6494-6498, 2009 | 450 | 2009 |
| Anticancer polymeric nanomedicines R Tong, J Cheng Journal of Macromolecular Science, Part C: Polymer Reviews 47 (3), 345-381, 2007 | 388 | 2007 |
| Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions A Mishra, GH Lai, NW Schmidt, VZ Sun, AR Rodriguez, R Tong, L Tang, ... Proceedings of the National Academy of Sciences 108 (41), 16883-16888, 2011 | 365 | 2011 |
| Near IR heptamethine cyanine dye–mediated cancer imaging X Yang, C Shi, R Tong, W Qian, HE Zhau, R Wang, G Zhu, J Cheng, ... Clinical cancer research 16 (10), 2833-2844, 2010 | 339 | 2010 |
| Spatiotemporal controlled delivery of nanoparticles to injured vasculature JM Chan, L Zhang, R Tong, D Ghosh, W Gao, G Liao, KP Yuet, D Gray, ... Proceedings of the National Academy of Sciences 107 (5), 2213-2218, 2010 | 277 | 2010 |
| Paclitaxel‐initiated, controlled polymerization of lactide for the formulation of polymeric nanoparticulate delivery vehicles R Tong, J Cheng Angewandte Chemie International Edition 47 (26), 4830-4834, 2008 | 231 | 2008 |
| Photoswitchable nanoparticles for in vivo cancer chemotherapy R Tong, HH Chiang, DS Kohane Proceedings of the National Academy of Sciences 110 (47), 19048-19053, 2013 | 230 | 2013 |
| Smart chemistry in polymeric nanomedicine R Tong, L Tang, L Ma, C Tu, R Baumgartner, J Cheng Chemical Society Reviews 43 (20), 6982-7012, 2014 | 201 | 2014 |
| Reprogramming the microenvironment with tumor-selective angiotensin blockers enhances cancer immunotherapy VP Chauhan, IX Chen, R Tong, MR Ng, JD Martin, K Naxerova, MW Wu, ... Proceedings of the National Academy of Sciences 116 (22), 10674-10680, 2019 | 172 | 2019 |
| Ring-opening polymerization-mediated controlled formulation of polylactide− drug nanoparticles R Tong, J Cheng Journal of the American Chemical Society 131 (13), 4744-4754, 2009 | 161 | 2009 |
| The formulation of aptamer-coated paclitaxel–polylactide nanoconjugates and their targeting to cancer cells R Tong, L Yala, TM Fan, J Cheng Biomaterials 31 (11), 3043-3053, 2010 | 149 | 2010 |
| Redox-responsive, core cross-linked polyester micelles Z Zhang, L Yin, C Tu, Z Song, Y Zhang, Y Xu, R Tong, Q Zhou, J Ren, ... ACS macro letters 2 (1), 40-44, 2013 | 128 | 2013 |
| New strategies in cancer nanomedicine R Tong, DS Kohane Annual review of pharmacology and toxicology 56 (1), 41-57, 2016 | 114 | 2016 |
| Polylactide-cyclosporin A nanoparticles for targeted immunosuppression J Azzi, L Tang, R Moore, R Tong, N El Haddad, T Akiyoshi, B Mfarrej, ... The FASEB Journal 24 (10), 3927, 2010 | 106 | 2010 |
| Wiley Interdiscip R Tong, DS Kohane Rev.: Nanomed. Nanobiotechnol 4, 638, 2012 | 104 | 2012 |
| Shedding light on nanomedicine R Tong, DS Kohane Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 4 (6 …, 2012 | 101 | 2012 |
| New chemistry in functional aliphatic polyesters R Tong Industrial & Engineering Chemistry Research 56 (15), 4207-4219, 2017 | 97 | 2017 |
| Anticancer nanoparticulate polymer‐drug conjugate Q Feng, R Tong Bioengineering & translational medicine 1 (3), 277-296, 2016 | 91 | 2016 |
| Nanomedicines targeting the tumor microenvironment R Tong, R Langer The Cancer Journal 21 (4), 314-321, 2015 | 85 | 2015 |
